Merci d'essayer une autre recherche
Libellé | Marché | Devise | ||
---|---|---|---|---|
IBO | CBOE Canada | CAD | Temps réel | |
IBO | TSXV | CAD | Différé |
Universal Ibogaine Inc. is a Canada-based life sciences company. The Company is focused on developing a network of addiction treatment clinics and undertake a planned clinical trial for research into the use of ibogaine for addiction treatment. Ibogaine is a neuroactive compound that appears to reset the brains of drug dependent individuals to a pre-addicted state. Ibogaine has demonstrated effectiveness in treating opioid use disorder and it appears to eliminate the painful symptoms of opioid withdrawal and provides a several month window free of drug cravings.
Nom | Age | Depuis | Titre |
---|---|---|---|
Nicholas Peter Karos | - | 2022 | CEO, Director of Capital Markets & Director |
James Duncan | - | 2023 | Independent Director |
Melissa Lavasani | - | 2023 | Member of Advisory Board |
Jerry Daniels | - | 2023 | Member of Advisory Board |
Amanda Zinter | - | 2023 | Member of Advisory Board |
Candice Wilson | - | 2023 | Member of Advisory Board |
Travis Hayes | - | 2023 | Member of Advisory Board |
Dean Koumontzis | - | 2023 | Independent Director |
Marcos Moura | - | 2023 | Member of Advisory Board |
Ken Cranwill | - | 2024 | Independent Director |
Voulez-vous vraiment bloquer %USER_NAME% ?
Si vous continuez, vous et %USER_NAME% ne verrez plus vos publications Investing.com mutuelles.
%USER_NAME% a bien été ajouté à votre Liste d’utilisateurs bloqués
Vous venez de débloquer cette personne et devrez attendre 48 heures avant de la bloquer de nouveau.
Je souhaite signaler ce commentaire comme:
Merci
Le commentaire signalé sera révisé par nos modérateurs